RE:RE:RE:RE:RE:RE:New Press Release - Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2I understand expenses can be incurred during a divestiture process but the revenue from a divestiture typically outweighs these costs. Maybe this cannot be blamed solely on the new CEO as these assets were acquired before his tenure but he was the one who promised shareholders he would cut costs and the level of expenses (in relation to revenues) in the latest fnancials was really unexpected.